Literature DB >> 24703459

Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism.

Mohamed A Elkoushy1, Alice X Yu2, Roger Tabah3, Richard J Payne4, Alice Dragomir5, Sero Andonian6.   

Abstract

OBJECTIVE: To assess the determinants of urolithiasis in patients with primary hyperparathyroidism (PHPT) before and after parathyroidectomy (PTX).
METHODS: Institutional Research Ethics approval was obtained. A retrospective review was performed for patients presenting with PHPT to the stone, surgical oncology, and otolaryngology clinics at 2 tertiary-care centers from January 2006 to November 2011. Demographic, clinical, and surgical data were collected together with 24-hour urine collections before and after PTX.
RESULTS: Of 332 patients undergoing PTX, 255 (68.2% female patients) had PHPT. Mean age was 60.3 years (range, 18-91). Before PTX, renal calcification was detected in 51 (20%) patients, nephrolithiasis in 48 (18.8%), and nephrocalcinosis in 3 (1.2%) patients. Compared with PHPT patients without stones, PHPT patients with stones were significantly younger (56.4 vs 61.3 years, P=.02), less likely to be female (54.9% vs 71.9%, P=.03), and had significantly lower levels of vitamin D (19.7 vs 23.5 ng/mL, P=.03). Nine patients (3.5%) developed stones after PTX and were found to have significantly higher post-PTX total serum calcium levels when compared with those without stones. Although hypercalciuria was detected in 62% of pre-PTX stone formers, none of those who tested had post-PTX hypercalciuria (P<.001). On multivariate regression analysis, post-PTX stone formation was associated with male gender (adjusted odds ratio [95% confidence interval]: 6.8 [5.3-7.2], P=.01) and post-PTX hypercalcemia (adjusted odds ratio [95% confidence interval]: 1.48 [1.33-2.12], P=.02).
CONCLUSION: Pre-PTX urolithiasis was associated with younger age, male gender, and lower levels of vitamin D, whereas post-PTX urolithiasis was independently predicted by male gender and hypercalcemia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24703459     DOI: 10.1016/j.urology.2014.01.016

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

2.  Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Authors:  F Saponaro; F Cetani; L Mazoni; M Apicella; M Di Giulio; F Carlucci; M Scalese; E Pardi; S Borsari; J P Bilezikian; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-12-23       Impact factor: 4.256

3.  Subclinical urolithiasis in patients with asymptomatic primary hyperparathyroidism.

Authors:  Hussam Abusahmin; John Geen; Gautam Das
Journal:  Ther Adv Endocrinol Metab       Date:  2018-07-24       Impact factor: 3.565

4.  Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.

Authors:  Giuseppe Viccica; Filomena Cetani; Edda Vignali; Mario Miccoli; Claudio Marcocci
Journal:  Endocrine       Date:  2016-03-31       Impact factor: 3.633

5.  Primary hyperparathyroidism and Klinefelter's syndrome in a young man.

Authors:  E Castellano; M Pellegrino; R Attanasio; V Guarnieri; A Maffè; G Borretta
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-04-01

6.  "Silent" kidney stones in "asymptomatic" primary hyperparathyroidism-a comparison of multidetector computed tomography and ultrasound.

Authors:  Andreas Selberherr; Marcus Hörmann; Gerhard Prager; Philipp Riss; Christian Scheuba; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2016-10-12       Impact factor: 3.445

7.  The prevalence of primary hyperparathyroidism in Korea: a population-based analysis from patient medical records.

Authors:  Jong-Kyu Kim; Young Jun Chai; Jung Kee Chung; Ki-Tae Hwang; Seung Chul Heo; Su-Jin Kim; June Young Choi; Ka Hee Yi; Sang Wan Kim; Sung Yong Cho; Kyu Eun Lee
Journal:  Ann Surg Treat Res       Date:  2018-04-30       Impact factor: 1.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.